Novabay Pharmaceuticals

Visual Financials
Company Name: NovaBay Pharmaceuticals Inc
Ticker Symbol: NBY
CIK Number: 0001389545
WWW Address: https://www.novabay.com
CEO: Mr. Justin M. Hall
No. of Employees: 78
Common Issue Type: CS
Business Description:NovaBay Pharmaceuticals, Inc., is a clinical-stage biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 1.15 Up 0.0685 - - 1.05 0.35 0.30 547350
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 21.8 19.0 0.00 -0.39 0.00 0.0 0.0 3.75 - 0.23
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.32$
PE Ratio - LTM0.0
Market Capitalisation21.8mil
Latest Shares Outstanding19.0mil
Earnings pS (EPS)-0.39$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee379,030$
Effective Tax Rate0.0%
Float5.3mil
Float as % of Shares Outstanding0.3%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue1.50%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin88.0%
EBITDA Margin-60.8%
Pre-Tax Profit Margin0.0%
Assets Turnover128.7%
Return on Assets (ROA)-67.3%
Return on Equity (ROE)-173.4%
Return on Capital Invested (ROCI)-173.4%
Current Ratio2.2
Leverage Ratio (Assets/Equity)1.9
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.25$
Cash pS0.00$
Book-Value pS0.06$
Tangible Book-Value pS0.26$
Cash Flow pS-0.49$
Free Cash Flow pS-0.49$
KEY FIGURES (LTM): Price info
Price/Book Ratio4.71
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----23.51,190,1055,071,642
4 Weeks0.870.230.41-21.11,887,64935,865,343
13 Weeks1.750.231.55-79.4597,03138,210,026
26 Weeks2.300.231.24-74.2317,83239,729,008
52 Weeks3.750.232.80-88.6166,85441,713,637
YTD2.300.23--67.7364,35439,350,237
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.330.320.751.121.250.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.290.30.42
Income0.0
Dividend0.0
Capital SpendingNA
R&D3.81NA7.54
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-22.7-22.7-37.0
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-0.02-0.02-0.04
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio50.86
Current Ratio2.2
Quick Ratio (Acid Test)1.7
Liquidity Ratio (Cash)1.65
Receivables Turnover3.6
Average Collection Period100
Working Capital/Equity96.1
Working Capital pS0.28
Cash-Flow pS-0.33
Free Cash-Flow pS-0.33
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-1.84
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.57
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA0.14
Enterprise Value (EV)/Free Cash Flow-2.04
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM4.71
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.75
Tangible Book Value pS - LTM0.26
Book Value pS - LTM0.06
Capital Invested pS0.26
Cash pS - LTM0.00
Cash Flow pS - LTM-0.49
Free Cash Flow pS - LTM-0.49
Earnings pS (EPS)-0.39
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-44.87
Free Cash Flow Margin 5YEAR AVG-409.04
Net Profit Margin-0.6
Net Profit Margin - 5YEAR AVRG.-4.2
Equity Productivity2.52
Return on Equity (ROE)-1.7
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity2.52
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity1.30
Return on Assets (ROA)-0.7
Return on Assets (ROA) - 5YEAR AVRG.-1.4
Gross Profit Margin88.0
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM-60.8
EBIT Margin - LTM-62.9
Pre-Tax Profit Margin-4.2
Pre-Tax Profit Margin - 5YEAR AVRG.-4.2
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee379,030
Net Income per Employee
Average Collection Period
Receivables Turnover3.6
Day's Inventory Turnover Ratio
Inventory Turnover3.8
Inventory/Sales2.2
Accounts Payble/Sales4.41
Assets/Revenue0.77
Net Working Capital Turnover2.63
Fixed Assets Turnover16.61
Total Assets Turnover1.3
Revenue per $ Cash3.93
Revenue per $ Plant62.23
Revenue per $ Common Equity2.52
Revenue per $ Capital Invested2.52
Selling, General & Adm/tive (SG&A) as % of Revenue148.8
SG&A Expense as % of Revenue - 5YEAR AVRG.1.1
Research & Devlopment (R&D) as % of Revenue2.1
R&D Expense as % of Revenue - 5YEAR AVRG.2.1

  


Your Recent History
AMEX
NBY
Novabay Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.